Wells Fargo & Company Surmodics Inc Transaction History

Wells Fargo & Company

$507 Billion
Q3 2025

A detailed history of Wells Fargo & Company transactions in Surmodics Inc stock. As of the latest transaction made, Wells Fargo & Company holds 8,653 shares of SRDX stock, worth $360,051. This represents 0.0% of its overall portfolio holdings.

Number of Shares

8,653

Previous 7,307 18.42%

Holding current value

$360,051

Previous $217,000 18.89%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 13, 2025	BUY	$29.0 - $38.0 $39,034 - $51,148	1,346 Added 18.42%	8,653 $258,000
Q2 2025 Aug 14, 2025	BUY	$26.76 - $31.1 $3,104 - $3,607	116 Added 1.61%	7,307 $217,000
Q1 2025 May 13, 2025	BUY	$26.71 - $39.71 $4,246 - $6,313	159 Added 2.26%	7,191 $219,000
Q4 2024 Feb 12, 2025	BUY	$37.5 - $40.13 $76,537 - $81,905	2,041 Added 40.89%	7,032 $278,000
Q3 2024 Nov 13, 2024	SELL	$38.47 - $42.24 $423 - $464	-11 Reduced 0.22%	4,991 $193,000

Q2 2024 Aug 13, 2024	BUY	$25.39 - $42.1 $18,128 - $30,059	714 Added 16.65%	5,002 $210,000
Q1 2024 May 10, 2024	BUY	$27.44 - $35.56 $19,647 - $25,460	716 Added 20.04%	4,288 $125,000
Q4 2023 Feb 09, 2024	BUY	$28.47 - $38.49 $20,356 - $27,520	715 Added 25.03%	3,572 $129,000
Q3 2023 Nov 13, 2023	SELL	$28.28 - $38.36 $84,642 - $114,811	-2,993 Reduced 51.16%	2,857 $91,000
Q2 2023 Aug 15, 2023	BUY	$17.67 - $31.31 $56,756 - $100,567	3,212 Added 121.76%	5,850 $183,000
Q1 2023 May 12, 2023	BUY	$17.13 - $38.52 $34,791 - $78,234	2,031 Added 334.6%	2,638 $60,000
Q4 2022 Feb 13, 2023	SELL	$29.44 - $37.31 $12,453 - $15,782	-423 Reduced 41.07%	607 $20,000
Q3 2022 Nov 14, 2022	SELL	$28.84 - $38.92 $3,778 - $5,098	-131 Reduced 11.28%	1,030 $31,000
Q2 2022 Aug 12, 2022	SELL	$33.25 - $45.11 $445,882 - $604,925	-13,410 Reduced 92.03%	1,161 $44,000
Q1 2022 May 16, 2022	SELL	$40.68 - $49.72 $213,895 - $261,427	-5,258 Reduced 26.52%	14,571 $661,000
Q4 2021 Feb 14, 2022	SELL	$43.21 - $57.6 $584,328 - $778,924	-13,523 Reduced 40.55%	19,829 $955,000
Q3 2021 Nov 15, 2021	BUY	$52.8 - $60.32 $197,313 - $225,415	3,737 Added 12.62%	33,352 $1.86 Million
Q2 2021 Aug 16, 2021	BUY	$51.29 - $59.15 $2,051 - $2,366	40 Added 0.14%	29,615 $1.61 Million
Q1 2021 May 13, 2021	SELL	$42.18 - $56.07 $482,243 - $641,048	-11,433 Reduced 27.88%	29,575 $1.66 Million
Q4 2020 Feb 09, 2021	SELL	$35.18 - $43.52 $8,091 - $10,009	-230 Reduced 0.56%	41,008 $1.79 Million
Q3 2020 Nov 05, 2020	BUY	$37.98 - $48.72 $244,439 - $313,561	6,436 Added 18.49%	41,238 $1.61 Million
Q2 2020 Aug 13, 2020	BUY	$31.07 - $44.74 $253,717 - $365,346	8,166 Added 30.66%	34,802 $1.51 Million
Q1 2020 May 14, 2020	BUY	$22.46 - $42.24 $598,244 - $1.13 Million	26,636 New	26,636 $888,000

Others Institutions Holding SRDX

# of Institutions

156

Shares Held

11.8M

Call Options Held

219K

Put Options Held

255K

View Full List

About SURMODICS INC

Ticker SRDX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 14,005,000
Market Cap $583M
Description
Surmodics, Inc., together with its subsidiaries, provides surface modification technologies for intravascular medical devices, and chemical components for in vitro diagnostic immunoassay tests and microarrays in the United States and internationally. It operates in two segments, Medical Device and In Vitro Diagnostics (IVD). The Medical Device s...

More about SRDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Account

Wells Fargo & Company Surmodics Inc Transaction History